QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

35,152 signal articles · 109 in last 24h · 178,699 total before filter · latest 29m ago

109last 24h

3128last 7d

511● bullish (7d)

313● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: MRKSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Insider Monkey41d agoneutral

Merck & Co (MRK) Has Billions in Revenue to Defend. Can its Pipeline Do the Job?

Trefis41d agoneutral

$85 Billion And Counting: JNJ Stock's Steady Cash-Return Habit

ABBV JNJ LLY MRK PFE

Trefis41d agoneutral

What Are Merck Stock Investors Overlooking?

ABBV BMY JNJ LLY MRK PFE

24/7 Wall St.41d agoneutral

Johnson & Johnson’s Next Growth Engine Is Taking Shape

TIKR41d agoneutral

Merck’s Forward P/E Nearly Doubled to 17x in a Year. Here’s What Its Pipeline Must Deliver by 2030

Zacks41d agoneutral

Merck, Daiichi Withdraw FDA Filing for Lung Cancer Therapy

Zacks41d agoneutral

FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication

Motley Fool41d agobullish

Up Over 550% in 2026, Is It Too Late to Buy Moderna Stock?

Zacks41d agoneutral

Is AstraZeneca's Oncology Portfolio Positioned for Continued Growth?

BioPharma Dive41d agoneutral

Merck, Daiichi end plans to seek speedy approval of lung cancer ADC

Stocktwits41d agoneutral

MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data

Simply Wall St.43d agoneutral

Why Moderna (MRNA) Is Up 29.1% After Melanoma Vaccine Success And Middle East Expansion Talks

TIKR43d agoneutral

Merck Is Up 40% This Year, but Is the Keytruda Rebuild Already Priced In?

Simply Wall St.44d agoneutral

Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval

Barchart44d agoneutral

Texas Instruments Is Up 56% YTD. 2 More Dividend Stocks Are Just as Hot.

Trefis44d agoneutral

Is LLY Stock Cheaper Than It Looks?

ABBV AMGN JNJ LLY MRK PFE

Trefis44d agoneutral

Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money?

ABBV BMY JNJ LLY MRK PFE

Zacks44d agoneutral

Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study

Quartz44d agoneutral

Merck remigromig DME trial results raise safety concerns

BioPharma Dive44d agobearish

Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data

TheStreet45d agoneutral

Bank of America has strong message for Merck stock investors

GuruFocus.com45d agobullish

Merck Jumps as Winrevair Moves Earlier in PAH

Trefis45d agoneutral

Can Eli Lilly Stock Catch Up To Rivals It Outgrows?

ABBV AMGN JNJ LLY MRK PFE

Investor's Business Daily45d agoneutral

These Dow Jones Stocks Buck Index's Dud Performance

AAPL BA CVX IBM MRK MSFT NKE PG+1

Benzinga45d agobearish

Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine

Insider Monkey45d agobearish

Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall?

Zacks45d agoneutral

Can Recent Traction With Key Drugs and Pipeline Progress Boost BMY?

24/7 Wall St.45d agoneutral

How a Roth IRA Can Keep Thousands More of Your DJIA Dividend Income Compounding

AMGN CVX GS IBM JPM MRK

Zacks45d agoneutral

Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans?

BioPharma Dive45d agoneutral

Merck reveals study success, and possible safety worries, for eye drug hopeful